Short description
Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.
Description
Next Science provides commercialising and developing its Xbio technology, which is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria, in a range of products for the treatment of biofilm based infections.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Chatswood, New South Wales, Australia, Oceania
Founded on
January 1, 2012
Exited on
May 21, 2019
Went public on
May 21, 2019
Stock symbol
NXSCF
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Founders
Matthew Myntti